Cytochrome P450 1 family and cancers

Journal of Steroid Biochemistry and Molecular Biology

Volumn 147, Issue , 2015, Pages 24-30

  Go, Ryeo Eun ^a   Hwang, Kyung A ^a   Choi, Kyung Chul ^a  

^a Chungbuk National University   (South Korea)

Author keywords

Aryl hydrocarbon receptor; Cytochrome P450 1 family; Estrogen receptor

Indexed keywords

CYTOCHROME P450; ESTROGEN RECEPTOR; AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1; ESTROGEN;

BLADDER CANCER; CANCER THERAPY; CYTOCHROME P450 GENE; ESTROGEN METABOLISM; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; GENE EXPRESSION; HUMAN; LIVER CANCER; MULTIGENE FAMILY; NEOPLASM; NONHUMAN; REVIEW; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM;

ANIMALS; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP1A2; CYTOCHROME P-450 CYP1B1; ESTROGENS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; RECEPTORS, ARYL HYDROCARBON; RECEPTORS, ESTROGEN;

EID: 84911904146     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2014.11.003     Document Type: Review

References (107)

1. D.C. Lamb, L. Lei, A.G. Warrilow, G.I. Lepesheva, J.G. Mullins, M.R. Waterman, and S.L. Kelly The first virally encoded cytochrome p450 J. Virol. 83 2009 8266 8269
2. A. Sigel, H. Sigel, and R.K.O. Sigel The Ubiquitous Roles of Cytochrome P450 Proteins: Metal Ions in Life Sciences 3 2007 Wiley 1 16
3. D. Fanni, R. Ambu, C. Gerosa, S. Nemolato, M. Castagnola, P. Van Eyken, G. Faa, and V. Fanos Cytochrome P450 genetic polymorphism in neonatal drug metabolism: role and practical consequences towards a new drug culture in neonatology Int. J. Immunopathol. Pharmacol. 27 2014 5 13
4. S.R. Beedanagari, I. Bebenek, P. Bui, and O. Hankinson Resveratrol inhibits dioxin-induced expression of human CYP1A1 and CYP1B1 by inhibiting recruitment of the aryl hydrocarbon receptor complex and RNA polymerase II to the regulatory regions of the corresponding genes Toxicol. Sci. 110 2009 61 67
5. D.R. Nelson, D.C. Zeldin, S.M. Hoffman, L.J. Maltais, H.M. Wain, and D.W. Nebert Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes including nomenclature recommendations for genes, pseudogenes and alternative-splice variants Pharmacogenetics 14 2004 1 18
6. R. Mikstacka, W. Baer-Dubowska, M. Wieczorek, and S. Sobiak Thiomethylstilbenes as inhibitors of CYP1A1, CYP1A2 and CYP1B1 activities Mol. Nutr. Food Res. 52 Suppl. 1 2008 S77 83
7. T. Shimada, C.L. Hayes, H. Yamazaki, S. Amin, S.S. Hecht, F.P. Guengerich, and T.R. Sutter Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1 Cancer Res. 56 1996 2979 2984
8. M. Sankhwar, and S.N. Sankhwar Variations in CYP isoforms and bladder cancer: a superfamily paradigm Urol. Oncol. 32 2014 e33 40
9. D.W. Nebert, and C.L. Karp Endogenous functions of the aryl hydrocarbon receptor (AHR): intersection of cytochrome P450 1 (CYP1)-metabolized eicosanoids and AHR biology J. Biol. Chem. 283 2008 36061 36065
10. P. Ramadoss, C. Marcus, and G.H. Perdew Role of the aryl hydrocarbon receptor in drug metabolism Expert Opin. Drug Metab. Toxicol. 1 2005 9 21
11. M.S. Denison, and S.R. Nagy Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals Annu. Rev. Pharmacol. Toxicol. 43 2003 309 334
12. F. Rataj, F.J. Moller, M. Jahne, O. Zierau, P. Diel, G. Vollmer, and G. Kretzschmar Regulation of uterine AHR battery gene expression by 17β-Estradiol is predominantly mediated by estrogen receptor alpha Arch. Toxicol. 86 2012 1603 1612
13. R. Barouki, M. Aggerbeck, L. Aggerbeck, and X. Coumoul The aryl hydrocarbon receptor system Drug Metabol. Drug Interact. 27 2012 3 8
14. J. Mimura, M. Ema, K. Sogawa, and Y. Fujii-Kuriyama Identification of a novel mechanism of regulation of Ah (dioxin) receptor function Genes Dev. 13 1999 20 25
15. V.P. Androutsopoulos, A.M. Tsatsakis, and D.A. Spandidos Cytochrome P450CYP1A1: wider roles in cancer progression and prevention BMC Cancer 9 2009 187
16. J.Y. Kim, S.G. Lee, J.Y. Chung, Y.J. Kim, J.E. Park, S. Oh, S.Y. Lee, H.J. Choi, Y.H. Yoo, and J.M. Kim 7,12-Dimethylbenzanthracene induces apoptosis in RL95-2 human endometrial cancer cells: ligand-selective activation of cytochrome P450 1B1 Toxicol. Appl. Pharmacol. 260 2012 124 134
17. P. Anand, A.B. Kunnumakkara, C. Sundaram, K.B. Harikumar, S.T. Tharakan, O.S. Lai, B. Sung, and B.B. Aggarwal Cancer is a preventable disease that requires major lifestyle changes Pharm. Res. 25 2008 2097 2116
18. S.H. Chung, S. Franceschi, and P.F. Lambert Estrogen and ERα: culprits in cervical cancer? Trends Endocrinol. Metab. 21 2010 504 511
19. J. Russo, M. Hasan Lareef, G. Balogh, S. Guo, and I.H. Russo Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells J. Steroid Biochem. Mol. Biol. 87 2003 1 25
20. C. Rodriguez, A.V. Patel, E.E. Calle, E.J. Jacob, and M.J. Thun Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women JAMA 285 2001 1460 1465
21. D. Grady, T. Gebretsadik, K. Kerlikowske, V. Ernster, and D. Petitti Hormone replacement therapy and endometrial cancer risk: a meta-analysis Obstet. Gynecol. 85 1995 304 313
22. P.L. Giacalone, J.P. Daures, L. Ouafik, P.M. Martin, F. Laffargue, and T. Maudelonde Steroids and adrenomedullin growth patterns in human ovarian cancer cells: estrogenic-regulation assay Gynecol. Oncol. 91 2003 651 656
23. K.A. Hwang, N.H. Kang, B.R. Yi, H.R. Lee, M.A. Park, and K.C. Choi Genistein a soy phytoestrogen, prevents the growth of BG-1 ovarian cancer cells induced by 17β-estradiol or bisphenol A via the inhibition of cell cycle progression Int. J. Oncol. 42 2012 733 740
24. K.A. Hwang, M.A. Park, N.H. Kang, B.R. Yi, S.H. Hyun, E.B. Jeung, and K.C. Choi Anticancer effect of genistein on BG-1 ovarian cancer growth induced by 17β-estradiol or bisphenol A via the suppression of the crosstalk between estrogen receptor alpha and insulin-like growth factor-1 receptor signaling pathways Toxicol. Appl. Pharmacol. 272 2013 637 646
25. B.R. Yi, K.A. Hwang, and K.C. Choi Hormonal implications in ovarian carcinogenesis: roles of reproductive hormones and their receptors J. Biomed. Res. 11 2010 81 91
26. H.R. Lee, and K.C. Choi 4-tert-Octylphenol stimulates the expression of cathepsins in human breast cancer cells and xenografted breast tumors of a mouse model via an estrogen receptor-mediated signaling pathway Toxicology 304 2013 13 20
27. H.R. Lee, K.A. Hwang, M.A. Park, B.R. Yi, E.B. Jeung, and K.C. Choi Treatment with bisphenol A and methoxychlor results in the growth of human breast cancer cells and alteration of the expression of cell cycle-related genes cyclin D1 and p21, via an estrogen receptor-dependent signaling pathway Int. J. Mol. Med. 29 2012 883 890
28. M.A. Park, K.A. Hwang, H.R. Lee, B.R. Yi, E.B. Jeung, and K.C. Choi Benzophenone-1 stimulated the growth of BG-1 ovarian cancer cells by cell cycle regulation via an estrogen receptor alpha-mediated signaling pathway in cellular and xenograft mouse models Toxicology 305 2013 41 48
29. Y. Tsuchiya, M. Nakajima, and T. Yokoi Cytochrome P450-mediated metabolism of estrogens and its regulation in human Cancer Lett. 227 2005 115 124
30. G.I. Murray, M.C. Taylor, M.C. McFadyen, J.A. McKay, W.F. Greenlee, M.D. Burke, and W.T. Melvin Tumor-specific expression of cytochrome P450CYP1B1 Cancer Res. 57 1997 3026 3031
31. H. Takemura, T. Itoh, K. Yamamoto, H. Sakakibara, and K. Shimoi Selective inhibition of methoxyflavonoids on human CYP1B1 activity Bioorg. Med. Chem. 18 2010 6310 6315
32. I. Hanukoglu Steroidogenic enzymes: structure, function, and role in regulation of steroid hormone biosynthesis J. Steroid Biochem. Mol. Biol. 43 1992 779 804
33. H. Szaefer, B. Licznerska, V. Krajka-Kuzniak, A. Bartoszek, and W. Baer-Dubowska Modulation of CYP1A1, CYP1A2 and CYP1B1 expression by cabbage juices and indoles in human breast cell lines Nutr. Cancer 64 2012 879 888
34. L. Muskhelishvili, P.A. Thompson, D.F. Kusewitt, C. Wang, and F.F. Kadlubar In situ hybridization and immunohistochemical analysis of cytochrome P450 1B1 expression in human normal tissues J. Histochem. Cytochem. 49 2001 229 236
35. R.R. Newbold, and J.G. Liehr Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens Cancer Res. 60 2000 235 237
36. H.K. Ghayee, and R.J. Auchus Basic concepts and recent developments in human steroid hormone biosynthesis Rev. Endocr. Metab. Disord. 8 2007 289 300
37. J.R. Petrulis, G. Chen, S. Benn, J. LaMarre, and N.J. Bunce Application of the ethoxyresorufin-O-deethylase (EROD) assay to mixtures of halogenated aromatic compounds Environ. Toxicol. 16 2001 177 184
38. D.S. Son, K.F. Roby, K.K. Rozman, and P.F. Terranova Estradiol enhances and estriol inhibits the expression of CYP1A1 induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in a mouse ovarian cancer cell line Toxicology 176 2002 229 243
39. M.P. Labrecque, M.K. Takhar, B.D. Hollingshead, G.G. Prefontaine, G.H. Perdew, and T.V. Beischlag Distinct roles for aryl hydrocarbon receptor nuclear translocator and ah receptor in estrogen-mediated signaling in human cancer cell lines PLoS One 7 2012 e29545
40. B. Wihlen, S. Ahmed, J. Inzunza, and J. Matthews Estrogen receptor subtype- and promoter-specific modulation of aryl hydrocarbon receptor-dependent transcription Mol. Cancer Res. 7 2009 977 986
41. W. Lim, Y. Park, J. Cho, C. Park, J. Park, Y.K. Park, H. Park, and Y. Lee Estrogen receptor beta inhibits transcriptional activity of hypoxia inducible factor-1 through the downregulation of arylhydrocarbon receptor nuclear translocator Breast Cancer Res. 13 2011 R32
42. L. Macpherson, and J. Matthews Inhibition of aryl hydrocarbon receptor-dependent transcription by resveratrol or kaempferol is independent of estrogen receptor alpha expression in human breast cancer cells Cancer Lett. 299 2010 119 129
43. J.G. Reeder, and V.G. Vogel Breast cancer prevention Cancer Treat. Res. 141 2008 149 164
44. Y. Gong, L.J. Dou, and J. Liang Link between obesity and cancer: role of triglyceride/free fatty acid cycling Eur. Rev. Med. Pharmacol. Sci. 19 2014 2808 2820
45. J.D. Yager, and N.E. Davidson Estrogen carcinogenesis in breast cancer New Engl. J. Med. 354 2006 270 282
46. J.G. Liehr, and M.J. Ricci 4-Hydroxylation of estrogens as marker of human mammary tumors Proc. Natl. Acad. Sci. U. S. A 93 1996 3294 3296
47. M.C. McFadyen, S. Breeman, S. Payne, C. Stirk, I.D. Miller, W.T. Melvin, and G.I. Murray Immunohistochemical localization of cytochrome P450CYP1B1 in breast cancer with monoclonal antibodies specific for CYP1B1 J. Histochem. Cytochem. 47 1999 1457 1464
48. J.A. McKay, W.T. Melvin, A.K. Ah-See, S.W. Ewen, W.F. Greenlee, C.B. Marcus, M.D. Burke, and G.I. Murray Expression of cytochrome P450CYP1B1 in breast cancer FEBS Lett. 374 1995 270 272
49. H.D. Soule, J. Vazguez, A. Long, S. Albert, and M. Brennan A human cell line from a pleural effusion derived from a breast carcinoma J. Natl. Cancer Inst. 51 1973 1409 1416
50. A.S. Levenson, and V.C. Jordan MCF-7: the first hormone-responsive breast cancer cell line Cancer Res. 57 1997 3071 3078
51. M. Lacroix, and G. Leclercq Relevance of breast cancer cell lines as models for breast tumours: an update Breast Cancer Res. Treat. 83 2004 249 289
52. D.T. Ross, and C.M. Perou A comparison of gene expression signatures from breast tumors and breast tissue derived cell lines Dis. Markers 17 2001 99 109
53. E. Charafe-Jauffret, C. Ginestier, F. Monville, P. Finetti, J. Adelaide, N. Cervera, S. Fekairi, L. Xerri, J. Jacquemier, D. Birnbaum, and F. Bertucci Gene expression profiling of breast cell lines identifies potential new basal markers Oncogene 25 2006 2273 2284
54. M. Lacroix, R.A. Toillon, and G. Leclercq p53 and breast cancer, an update Endocr. Relat. Cancer 13 2006 293 325
55. Y. Tsuchiya, M. Nakajima, S. Kyo, T. Kanaya, M. Inoue, and T. Yokoi Human CYP1B1 is regulated by estradiol via estrogen receptor Cancer Res. 64 2004 3119 3125
56. N.A. Englert, R.J. Turesky, W. Han, E.E. Bessette, S.D. Spivack, M. Caggana, D.C. Spink, and B.C. Spink Genetic and epigenetic regulation of AHR gene expression in MCF-7 breast cancer cells: role of the proximal promoter GC-rich region Biochem. Pharmacol. 84 2012 722 735
57. I.A.F.R. O. Cancer, 2014. World Health Organization., World Cancer Report Chapter 6, 7.
58. O.S. Kerimoglu, A. Pekin, and S.A. Yilmaz Effect of the percentage of body fat on surgical, clinical and pathological outcomes in women with endometrial cancer J. Obstet. Gynaecol. Res. 2014 1 7
59. X. Han, and J.G. Liehr DNA single-strand breaks in kidneys of Syrian hamsters treated with steroidal estrogens: hormone-induced free radical damage preceding renal malignancy Carcinogenesis 15 1994 997 1000
60. J.G. Liehr, M.J. Ricci, C.R. Jefcoate, E.V. Hannigan, J.A. Hokanson, and T. Zhu 4-Hydroxylation of estradiol by human uterine myometrium and myoma microsomes: implications for the mechanism of uterine tumorigenesis Proc. Natl. Acad. Sci. U. S. A. 92 1995 9220 9224
61. G.P. Alsbach, E.R. Franck, J. Poortman, and J.H. Thijssen Subcellular distribution of estradiol and estrone in human endometrium and myometrium during the menstrual cycle Contraception 27 1983 409 421
62. H.M. Lemon, J.W. Heidel, and J.F. Rodriguez-Sierra Increased catechol estrogen metabolism as a risk factor for nonfamilial breast cancer Cancer 69 1992 457 465
63. H. Bao, M. Vepakomma, and M.A. Sarkar Benzo(a) pyrene exposure induces CYP1A1 activity and expression in human endometrial cells J. Steroid Biochem. Mol. Biol. 81 2002 37 45
64. T. Shimada, H. Yamazaki, M. Foroozesh, N.E. Hopkins, W.L. Alworth, and F.P. Guengerich Selectivity of polycyclic inhibitors for human cytochrome P450s 1A1, 1A2, and 1B1 Chem. Res. Toxicol. 11 1998 1048 1056
65. L.M. Berstein, E.V. Tsyrlina, V.B. Gamajunova, N.V. Bychkova, O.G. Krjukova, S.V. Dzhumasultanova, I.G. Kovalenko, and O.S. Kolesnik Study of tobacco smoke influence on content of estrogens and DNA flow cytometry data in uterine tissue of rats of different age Horm. Metab. Res. 31 1999 27 30
66. Y. Zhuge, J.A. Lagman, K. Ansenberger, C.J. Mahon, T. Daikoku, S.K. Dey, J.M. Bahr, and D.B. Hales CYP1B1 expression in ovarian cancer in the laying hen Gallusdomesticus Gynecol. Oncol. 112 2009 171 178
67. C.H. Holschneider, and J.S. Berek Ovarian cancer: epidemiology, biology, and prognostic factors Semin. Surg. Oncol. 19 2000 3 10
68. H. Kuper, L. Titus-Ernstoff, B.L. Harlow, and D.W. Cramer Population based study of coffee, alcohol and tobacco use and risk of ovarian cancer Int. J. Cancer 88 2000 313 318
69. P.A. Marchbanks, H. Wilson, E. Bastos, D.W. Cramer, J.M. Schildkraut, and H.B. Peterson Cigarette smoking and epithelial ovarian cancer by histologic type Obstet. Gynecol. 95 2000 255 260
70. J.P. Whitlock Jr. Induction of cytochrome P4501A1 Annu. Rev. Pharmacol. Toxicol. 39 1999 103 125
71. Y.K. Leung, K.M. Lau, J. Mobley, Z. Jiang, and S.M. Ho Overexpression of cytochrome P450 1A1 and its novel spliced variant in ovarian cancer cells: alternative subcellular enzyme compartmentation may contribute to carcinogenesis Cancer Res. 65 2005 3726 3734
72. T. Shimada, and Y. Fujii-Kuriyama Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and 1B1 Cancer Sci. 95 2004 1 6
73. D. Schwarz, P. Kisselev, S.S. Ericksen, G.D. Szklarz, A. Chernogolov, H. Honeck, W.H. Schunck, and I. Roots Arachidonic and eicosapentaenoic acid metabolism by human CYP1A1: highly stereoselective formation of 17(R), 18(S)-epoxyeicosatetraenoic acid Biochem. Pharmacol. 67 2004 1445 1457
74. C. Macica, M. Balazy, J.R. Falck, C. Mioskowski, and M.A. Carroll Characterization of cytochrome P-450-dependent arachidonic acid metabolism in rabbit intestine Am. J. Physiol. 265 1993 G735 741
75. J.C. McGiff Cytochrome P-450 metabolism of arachidonic acid Annu. Rev. Pharmacol. Toxicol. 31 1991 339 369
76. D. Sacerdoti, B.A. Escalante, M.L. Schwartzman, N.G. Abraham, A. Gatta, and J.C. McGiff Renal cytochrome P-450-dependent metabolism of arachidonic acid in cirrhotic rats J. Hepatol. 12 1991 230 235
77. C.R. Chiaro, R.D. Patel, and G.H. Perdew 12(R)-Hydroxy-5(Z) 8(Z),10(E), 14(Z)-eicosatetraenoic acid [12(R)-HETE], an arachidonic acid derivative, is an activator of the aryl hydrocarbon receptor Mol. Pharmacol. 74 2008 1649 1656
78. S. Kasai, T. Ishigaki, R. Takumi, T. Kamimura, and H. Kikuchi Beta-catenin signaling induces CYP1A1 expression by disrupting adherens junctions in Caco-2 human colon carcinoma cells Biochim. Biophys. Acta 1830 2013 2509 2516
79. A. Braeuning, C. Kohle, A. Buchmann, and M. Schwarz Coordinate regulation of cytochrome P450 1a1 expression in mouse liver by the aryl hydrocarbon receptor and the beta-catenin pathway Toxicol. Sci. 122 2011 16 25
80. M. Rodriguez, and D.A. Potter CYP1A1 regulates breast cancer proliferation and survival Mol. Cancer Res. 11 2013 780 792
81. L. Kanetis, H. Forster, C.A. Jones, K.A. Borkovich, and J.E. Adaskaveg Characterization of genetic and biochemical mechanisms of fludioxonil and pyrimethanil resistance in field isolates of Penicillium digitatum Phytopathology 98 2008 205 214
82. V. Lecureur, E.L. Ferrec, M. N'Diaye, M.L. Vee, C. Gardyn, D. Gilot, and O. Fardel ERK-dependent induction of TNFalpha expression by the environmental contaminant benzo(a) pyrene in primary human macrophages FEBS Lett. 579 2005 1904 1910
83. P. Cabras, A. Angioni, V.L. Garau, and E.V. Minelli Gas chromatographic determination of cyprodinil, fludioxonil, pyrimethanil, and tebuconazole in grapes must, and wine J. AOAC Int. 80 1997 867 870
84. C.C. Fang, F.Y. Chen, C.R. Chen, C.C. Liu, L.C. Wong, Y.W. Liu, and J.G. Su Cyprodinil as an activator of aryl hydrocarbon receptor Toxicology 304 2013 32 40
85. R. Haas Determination of chemical warfare agents: gas chromatographic analysis of chlorovinylarsines (Lewisite) and their metabolites by derivatization with thiols (2nd communication) Environ. Sci. Pollut. Res. Int. 5 1998 2 3
86. R. Haas Determination of chemical warfare agents: gas chromatographic analysis of ethylarsine dichloride by derivatization with dithiols (3rd communication) Environ. Sci. Pollut. Res. Int. 5 1998 63 64
87. S. Hanaoka, K. Nomura, and S. Kudo Identification and quantitative determination of diphenylarsenic compounds in abandoned toxic smoke canisters J. Chromatogr. 1085 2005 213 223
88. T. Arao, Y. Maejima, and K. Baba Uptake of aromatic arsenicals from soil contaminated with diphenylarsinic acid by rice Environ. Sci. Technol. 43 2009 1097 1101
89. IARC, 2004. Some drinking-water disinfectants and contaminants, including arsenic.
90. S.M. Cohen, L.L. Arnold, M. Eldan, A.S. Lewis, and B.D. Beck Methylated arsenicals: the implications of metabolism and carcinogenicity studies in rodents to human risk assessment Crit. Rev. Toxicol. 36 2006 99 133
91. Y. Tsuchiya, M. Nakajima, and T. Yokoi Critical enhancer region to which AhR/ARNT and Sp1 bind in the human CYP1B1 gene J. Biochem. 133 2003 583 592
92. D.W. Nebert, and T.P. Dalton The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis Nat. Rev. 6 2006 947 960
93. H. Tsuda, S. Fukushima, H. Wanibuchi, K. Morimura, D. Nakae, K. Imaida, M. Tatematsu, M. Hirose, K. Wakabayashi, and M.A. Moore Value of GST-P positive preneoplastic hepatic foci in dose-response studies of hepatocarcinogenesis: evidence for practical thresholds with both genotoxic and nongenotoxic carcinogens. A review of recent work Toxicol. Pathol. 31 2003 80 86
94. K.W. Jung, S. Park, H.J. Kong, Y.J. Won, J.Y. Lee, E.C. Park, and J.S. Lee Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2011 Cancer Res. Treat. 46 2014 109 123
95. C.N. Sternberg, S.M. Donat, J. Bellmunt, R.E. Millikan, W. Stadler, P. De Mulder, A. Sherif, H. von der Maase, T. Tsukamoto, and M.S. Soloway Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer Urology 69 2007 62 79
96. J. Zhang, B. Yang, B. Ying, D. Li, Y. Shi, X. Song, B. Cai, Z. Huang, Y. Wu, and L. Wang Association of pre-microRNAs genetic variants with susceptibility in systemic lupus erythematosus Mol. Biol. Rep. 38 2010 1463 1468
97. N. Bozina, V. Bradamante, and M. Lovric Genetic polymorphism of metabolic enzymes P450 (CYP) as a susceptibility factor for drug response, toxicity, and cancer risk Arh. Hig. Rada Toksikol. 60 2009 217 242
98. C. Xu, C.Y. Li, and A.N. Kong Induction of phase I, II and III drug metabolism/transport by xenobiotics Arch. Pharm. Res. 28 2005 249 268
99. S. Jana, and J. Paliwal Molecular mechanisms of cytochrome p450 induction: potential for drug-drug interactions Curr. Protein Pept. Sci. 8 2007 619 628
100. F.P. Guengerich Cytochromes P450, drugs, and diseases Mol. Interv. 3 2003 194 204
101. F.P. Guengerich Cytochrome p450 and chemical toxicology Chem. Res. Toxicol. 21 2008 70 83
102. V.P. Androutsopoulos, I. Spyrou, A. Ploumidis, A.E. Papalampros, M. Kyriakakis, D. Delakas, D.A. Spandidos, and A.M. Tsatsakis Expression profile of CYP1A1 and CYP1B1 enzymes in colon and bladder tumors PloS One 8 2013 e82487
103. M. Sutherland, J.H. Gill, P.M. Loadman, J.P. Laye, H.M. Sheldrake, N.A. Illingworth, M.N. Alandas, P.A. Cooper, M. Searcey, K. Pors, S.D. Shnyder, and L.H. Patterson Antitumor activity of a duocarmycin analogue rationalized to be metabolically activated by cytochrome P450 1A1 in human transitional cell carcinoma of the bladder Mol. Cancer Ther. 12 2012 27 37
104. S.H. Kim, and K.C. Choi Anti-cancer effect and underlying mechanism(s) of Kaempferol a phytoestrogen, on the regulation of apoptosis in diverse cancer cell models Toxicol. Res. 29 2013 229 234
105. N.H. Kang, K.A. Hwang, H.R. Lee, D.W. Choi, and K.C. Choi Resveratrol regulates the cell viability promoted by 17β-estradiol or bisphenol A via down-regulation of the cross-talk between estrogen receptor alpha and insulin growth factor-1 receptor in BG-1 ovarian cancer cells Food Chem. Toxicol. 59 2013 373 379
106. D. Ung, and S. Nagar Trans-resveratrol-mediated inhibition of beta-oestradiol conjugation in MCF-7 cells stably expressing human sulfotransferases SULT1A1 or SULT1E1, and human liver microsomes Xenobiotica 39 2009 72 79
107. L. Stejskalova, A. Rulcova, R. Vrzal, Z. Dvorak, and P. Pavek Dexamethasone accelerates degradation of aryl hydrocarbon receptor (AHR) and suppresses CYP1A1 induction in placental JEG-3 cell line Toxicol. Lett. 223 2013 183 191